Neuroprotective Strategies for Newborns View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2018-10-10

AUTHORS

Bobbi Fleiss , Claire Thornton , Pierre Gressens

ABSTRACT

Perinatal brain injury is the leading cause of death and disability in children. Such damage can be induced by multiple factors, varies in severity between individuals, affects infants of different genetic backgrounds, and occurs at various stages of the physiological developmental program. This complexity creates innumerable difficulties in creating therapeutic agents. A wealth of experimental studies has engaged in the understanding of brain injury pathophysiology and in the development of strategies that may be beneficial for the neurological outcome of infants. Clinical trials have demonstrated the partial neuroprotective effects of hypothermia and magnesium sulfate in human neonates. Trials for the neuroprotective effects of the pluripotent hormone melatonin are ongoing. In the following chapter we review the experimental and clinical data on neuroprotective strategies. More... »

PAGES

2185-2199

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-319-29489-6_274

DOI

http://dx.doi.org/10.1007/978-3-319-29489-6_274

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1107513347


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Centre for the Developing Brain, Department of Perinatal Imaging and Health, Division of Imaging Sciences and Biomedical Engineering, King\u2019s College London, King\u2019s Health Partners, St. Thomas\u2019 Hospital, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.13097.3c", 
          "name": [
            "UMR1141, Insem-Paris Diderot University, H\u00f4pital Robert Debr\u00e9, Paris, France", 
            "Centre for the Developing Brain, Department of Perinatal Imaging and Health, Division of Imaging Sciences and Biomedical Engineering, King\u2019s College London, King\u2019s Health Partners, St. Thomas\u2019 Hospital, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fleiss", 
        "givenName": "Bobbi", 
        "id": "sg:person.0753527762.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753527762.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre for the Developing Brain, Department of Perinatal Imaging and Health, Division of Imaging Sciences and Biomedical Engineering, King\u2019s College London, King\u2019s Health Partners, St. Thomas\u2019 Hospital, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.13097.3c", 
          "name": [
            "Centre for the Developing Brain, Department of Perinatal Imaging and Health, Division of Imaging Sciences and Biomedical Engineering, King\u2019s College London, King\u2019s Health Partners, St. Thomas\u2019 Hospital, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thornton", 
        "givenName": "Claire", 
        "id": "sg:person.01320370723.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320370723.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre for the Developing Brain, Department of Perinatal Imaging and Health, Division of Imaging Sciences and Biomedical Engineering, King\u2019s College London, King\u2019s Health Partners, St. Thomas\u2019 Hospital, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.13097.3c", 
          "name": [
            "UMR1141, Insem-Paris Diderot University, H\u00f4pital Robert Debr\u00e9, Paris, France", 
            "Centre for the Developing Brain, Department of Perinatal Imaging and Health, Division of Imaging Sciences and Biomedical Engineering, King\u2019s College London, King\u2019s Health Partners, St. Thomas\u2019 Hospital, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gressens", 
        "givenName": "Pierre", 
        "id": "sg:person.0643134421.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643134421.39"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2018-10-10", 
    "datePublishedReg": "2018-10-10", 
    "description": "Perinatal brain injury is the leading cause of death and disability in children. Such damage can be induced by multiple factors, varies in severity between individuals, affects infants of different genetic backgrounds, and occurs at various stages of the physiological developmental program. This complexity creates innumerable difficulties in creating therapeutic agents. A wealth of experimental studies has engaged in the understanding of brain injury pathophysiology and in the development of strategies that may be beneficial for the neurological outcome of infants. Clinical trials have demonstrated the partial neuroprotective effects of hypothermia and magnesium sulfate in human neonates. Trials for the neuroprotective effects of the pluripotent hormone melatonin are ongoing. In the following chapter we review the experimental and clinical data on neuroprotective strategies.", 
    "editor": [
      {
        "familyName": "Buonocore", 
        "givenName": "Giuseppe", 
        "type": "Person"
      }, 
      {
        "familyName": "Bracci", 
        "givenName": "Rodolfo", 
        "type": "Person"
      }, 
      {
        "familyName": "Weindling", 
        "givenName": "Michael", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-319-29489-6_274", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-319-29487-2", 
        "978-3-319-29489-6"
      ], 
      "name": "Neonatology", 
      "type": "Book"
    }, 
    "keywords": [
      "neuroprotective effects", 
      "neuroprotective strategies", 
      "partial neuroprotective effects", 
      "perinatal brain injury", 
      "brain injury pathophysiology", 
      "cause of death", 
      "neurological outcome", 
      "injury pathophysiology", 
      "brain injury", 
      "clinical trials", 
      "human neonates", 
      "clinical data", 
      "hormone melatonin", 
      "therapeutic agents", 
      "magnesium sulfate", 
      "development of strategies", 
      "infants", 
      "trials", 
      "multiple factors", 
      "different genetic backgrounds", 
      "genetic background", 
      "neonates", 
      "pathophysiology", 
      "hypothermia", 
      "newborns", 
      "injury", 
      "such damage", 
      "innumerable difficulties", 
      "severity", 
      "melatonin", 
      "death", 
      "outcomes", 
      "disability", 
      "children", 
      "cause", 
      "following chapter", 
      "effect", 
      "agents", 
      "damage", 
      "individuals", 
      "strategies", 
      "factors", 
      "study", 
      "background", 
      "developmental program", 
      "stage", 
      "program", 
      "experimental study", 
      "difficulties", 
      "development", 
      "data", 
      "varies", 
      "sulfate", 
      "understanding", 
      "chapter", 
      "wealth", 
      "complexity", 
      "physiological developmental program", 
      "pluripotent hormone melatonin"
    ], 
    "name": "Neuroprotective Strategies for Newborns", 
    "pagination": "2185-2199", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1107513347"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-319-29489-6_274"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-319-29489-6_274", 
      "https://app.dimensions.ai/details/publication/pub.1107513347"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2021-11-01T19:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/chapter/chapter_446.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-319-29489-6_274"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-29489-6_274'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-29489-6_274'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-29489-6_274'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-29489-6_274'


 

This table displays all metadata directly associated to this object as RDF triples.

144 TRIPLES      23 PREDICATES      83 URIs      76 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-319-29489-6_274 schema:about anzsrc-for:11
2 anzsrc-for:1109
3 schema:author N5029efea78e643efa67b4d4c2e0ebe7a
4 schema:datePublished 2018-10-10
5 schema:datePublishedReg 2018-10-10
6 schema:description Perinatal brain injury is the leading cause of death and disability in children. Such damage can be induced by multiple factors, varies in severity between individuals, affects infants of different genetic backgrounds, and occurs at various stages of the physiological developmental program. This complexity creates innumerable difficulties in creating therapeutic agents. A wealth of experimental studies has engaged in the understanding of brain injury pathophysiology and in the development of strategies that may be beneficial for the neurological outcome of infants. Clinical trials have demonstrated the partial neuroprotective effects of hypothermia and magnesium sulfate in human neonates. Trials for the neuroprotective effects of the pluripotent hormone melatonin are ongoing. In the following chapter we review the experimental and clinical data on neuroprotective strategies.
7 schema:editor N8fa5a45103944ee7bf3bfa1af30cb0dd
8 schema:genre chapter
9 schema:inLanguage en
10 schema:isAccessibleForFree false
11 schema:isPartOf Ne17a6eebe61248d49a9c4a6ab54f42d9
12 schema:keywords agents
13 background
14 brain injury
15 brain injury pathophysiology
16 cause
17 cause of death
18 chapter
19 children
20 clinical data
21 clinical trials
22 complexity
23 damage
24 data
25 death
26 development
27 development of strategies
28 developmental program
29 different genetic backgrounds
30 difficulties
31 disability
32 effect
33 experimental study
34 factors
35 following chapter
36 genetic background
37 hormone melatonin
38 human neonates
39 hypothermia
40 individuals
41 infants
42 injury
43 injury pathophysiology
44 innumerable difficulties
45 magnesium sulfate
46 melatonin
47 multiple factors
48 neonates
49 neurological outcome
50 neuroprotective effects
51 neuroprotective strategies
52 newborns
53 outcomes
54 partial neuroprotective effects
55 pathophysiology
56 perinatal brain injury
57 physiological developmental program
58 pluripotent hormone melatonin
59 program
60 severity
61 stage
62 strategies
63 study
64 such damage
65 sulfate
66 therapeutic agents
67 trials
68 understanding
69 varies
70 wealth
71 schema:name Neuroprotective Strategies for Newborns
72 schema:pagination 2185-2199
73 schema:productId N10e6f4a72d08484fbb151ab0dfccb378
74 Na4f64021037840e695f70af8141cd3da
75 schema:publisher Naa10c26bfe5a47c39bb4463d6186912e
76 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107513347
77 https://doi.org/10.1007/978-3-319-29489-6_274
78 schema:sdDatePublished 2021-11-01T19:01
79 schema:sdLicense https://scigraph.springernature.com/explorer/license/
80 schema:sdPublisher N44302ed7d1ed45d1ae296858976bb00b
81 schema:url https://doi.org/10.1007/978-3-319-29489-6_274
82 sgo:license sg:explorer/license/
83 sgo:sdDataset chapters
84 rdf:type schema:Chapter
85 N10e6f4a72d08484fbb151ab0dfccb378 schema:name dimensions_id
86 schema:value pub.1107513347
87 rdf:type schema:PropertyValue
88 N44302ed7d1ed45d1ae296858976bb00b schema:name Springer Nature - SN SciGraph project
89 rdf:type schema:Organization
90 N5029efea78e643efa67b4d4c2e0ebe7a rdf:first sg:person.0753527762.82
91 rdf:rest N51b5f7f6ce854780bdd5479efb37a741
92 N51b5f7f6ce854780bdd5479efb37a741 rdf:first sg:person.01320370723.58
93 rdf:rest Nebb5c9403834443fac542124e4c6be8c
94 N70de26df7c6a42aba26d9a23464b94c5 schema:familyName Buonocore
95 schema:givenName Giuseppe
96 rdf:type schema:Person
97 N795bb1387c064741b017e990727a673a rdf:first Nbba5761bf83d4f02ae54b58f99399521
98 rdf:rest rdf:nil
99 N8fa5a45103944ee7bf3bfa1af30cb0dd rdf:first N70de26df7c6a42aba26d9a23464b94c5
100 rdf:rest N9d6021ae2dea4d718227ddcf84252df5
101 N9d6021ae2dea4d718227ddcf84252df5 rdf:first Nb8eadafc8d1c46beb6f7e1a4318741e5
102 rdf:rest N795bb1387c064741b017e990727a673a
103 Na4f64021037840e695f70af8141cd3da schema:name doi
104 schema:value 10.1007/978-3-319-29489-6_274
105 rdf:type schema:PropertyValue
106 Naa10c26bfe5a47c39bb4463d6186912e schema:name Springer Nature
107 rdf:type schema:Organisation
108 Nb8eadafc8d1c46beb6f7e1a4318741e5 schema:familyName Bracci
109 schema:givenName Rodolfo
110 rdf:type schema:Person
111 Nbba5761bf83d4f02ae54b58f99399521 schema:familyName Weindling
112 schema:givenName Michael
113 rdf:type schema:Person
114 Ne17a6eebe61248d49a9c4a6ab54f42d9 schema:isbn 978-3-319-29487-2
115 978-3-319-29489-6
116 schema:name Neonatology
117 rdf:type schema:Book
118 Nebb5c9403834443fac542124e4c6be8c rdf:first sg:person.0643134421.39
119 rdf:rest rdf:nil
120 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
121 schema:name Medical and Health Sciences
122 rdf:type schema:DefinedTerm
123 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
124 schema:name Neurosciences
125 rdf:type schema:DefinedTerm
126 sg:person.01320370723.58 schema:affiliation grid-institutes:grid.13097.3c
127 schema:familyName Thornton
128 schema:givenName Claire
129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320370723.58
130 rdf:type schema:Person
131 sg:person.0643134421.39 schema:affiliation grid-institutes:grid.13097.3c
132 schema:familyName Gressens
133 schema:givenName Pierre
134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643134421.39
135 rdf:type schema:Person
136 sg:person.0753527762.82 schema:affiliation grid-institutes:grid.13097.3c
137 schema:familyName Fleiss
138 schema:givenName Bobbi
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753527762.82
140 rdf:type schema:Person
141 grid-institutes:grid.13097.3c schema:alternateName Centre for the Developing Brain, Department of Perinatal Imaging and Health, Division of Imaging Sciences and Biomedical Engineering, King’s College London, King’s Health Partners, St. Thomas’ Hospital, London, UK
142 schema:name Centre for the Developing Brain, Department of Perinatal Imaging and Health, Division of Imaging Sciences and Biomedical Engineering, King’s College London, King’s Health Partners, St. Thomas’ Hospital, London, UK
143 UMR1141, Insem-Paris Diderot University, Hôpital Robert Debré, Paris, France
144 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...